- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
Weekly Investor Report
V.S. International Group Limited ยท Basic Materials ยท Specialty Chemicals
Mixed setup
The weekly trend is not active. Price is -8.6% below the Trend Line and sits at 16.1% of its 52-week range. The latest completed week returned -3.8%, after a 8.7% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Where price isโand whether the trend supports it
The weekly trend is not active. Price is -8.6% below the Trend Line and sits at 16.1% of its 52-week range. The latest completed week returned -3.8%, after a 8.7% four-week move.
52-week price path
Price vs Trend Line and Fair ValueIs real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price directionActivity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
12-week confirmation
No recent accumulation markers. No reversal markers.
Is performance persistentโand is the stock leading?
Performance is 8.7% over four weeks, -10.7% over 12 weeks, and -3.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Activity pressure vs relative leadership
What investors are paying forโand the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
No recent insider transactions are stored for this company.
Weighted news tone is neutral across 2 relevant articles.
1 positive ยท 1 neutral ยท 0 negativeActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signalWhat can move the sharesโand how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
Shape of recent returns
Is this stock leadingโor simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
Four-week leaders
Four-week leaders
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis25/100Latest 12-week confirmation: trend 3/12, activity pressure 3/12, relative leadership 2/12.
Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 43.81%Next-week expectancy is negative with a 43.81% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 2 relevant articles.
Novelix Pharma Q1 FY27 Results: Revenue Rs 36 Cr, PAT Surges 1002% Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 4 Sep 2026 | 0.05 HKD | -3.8% | 0.0547 HKD | 0.0675 HKD | -0.27 | -7.82 | 1.5M | Off |
| 28 Aug 2026 | 0.052 HKD | -1.9% | 0.055 HKD | 0.0677 HKD | -0.27 | -3.97 | 16.3M | Off |
| 21 Aug 2026 | 0.053 HKD | 6.0% | 0.055 HKD | 0.0678 HKD | -0.57 | -3.76 | 19.2M | Off |
| 14 Aug 2026 | 0.05 HKD | 8.7% | 0.055 HKD | 0.068 HKD | -0.82 | -5.99 | 15.6M | Off |
| 7 Aug 2026 | 0.046 HKD | 0.0% | 0.0551 HKD | 0.0682 HKD | -0.92 | -15.45 | 2.8M | Off |
| 31 Jul 2026 | 0.046 HKD | 0.0% | 0.0554 HKD | 0.0684 HKD | -0.87 | -16.44 | 0 | Off |
| 24 Jul 2026 | 0.046 HKD | -8.0% | 0.0556 HKD | 0.0686 HKD | -0.44 | -13.63 | 2.2M | Off |
| 17 Jul 2026 | 0.05 HKD | 0.0% | 0.0558 HKD | 0.0688 HKD | -0.33 | -4.80 | 48.0K | Off |
| 10 Jul 2026 | 0.05 HKD | -13.8% | 0.0558 HKD | 0.069 HKD | -0.03 | -3.43 | 56.0K | Off |
| 3 Jul 2026 | 0.058 HKD | 13.7% | 0.0559 HKD | 0.0693 HKD | 0.16 | 15.98 | 6.5M | On |
| 26 Jun 2026 | 0.051 HKD | 0.0% | 0.0558 HKD | 0.0695 HKD | 0.44 | 5.25 | 140.0K | On |
| 19 Jun 2026 | 0.051 HKD | -8.9% | 0.056 HKD | 0.0697 HKD | 0.80 | -0.24 | 5.0M | On |
| 12 Jun 2026 | 0.056 HKD | -30.9% | 0.0561 HKD | 0.0699 HKD | 0.81 | 5.83 | 300.0K | On |
| 5 Jun 2026 | 0.081 HKD | 24.6% | 0.0562 HKD | 0.0702 HKD | 0.74 | 51.24 | 2.7M | On |
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.